Requires NJ FamilyCare to reimburse inpatient providers for long-acting injectable antipsychotic drugs at outpatient reimbursement rate.

This bill requires New Jersey's Medicaid program (NJ FamilyCare) to reimburse hospitals for long-acting injectable antipsychotic drugs at the same rate used for outpatient settings, rather than including these costs in standard hospital payment systems. It directly affects inpatient hospitals and providers who administer these drugs for conditions like schizophrenia or bipolar disorder. The key change ensures hospitals receive payment based on the actual drug cost (like outpatient settings) instead of a fixed hospital payment rate that doesn't account for expensive medications. The bill also allows qualified pharmacists to administer these drugs under a prescriber's order, with state board oversight.